Rectal Cancer – organ preserving treatment (extension to CR29)
Project summary
The EORTC colorectal module (QLQ-CR29) is the most commonly used patient reported outcome measure in colorectal cancer clinical trials. The results of the updated colorectal module validation were published in 2009. However, since then the treatment landscape has changed for example, with the introduction of molecular targeted treatments and organ preservation approaches to treatment. The aim of this project is to update the QLQ-CR29 and provide an opportunity to amend the wording on relevant items and to add or remove items as relevant.
Achievements
Research fellow in post 1st September 2025
Current status:
Scoping review and ethics application under way
Future plans
Health care and patient interviews to start Q1-2 2026
For patients
To update the EORTC QLQ-CR29 (which was last updated in 2009), to ensure our questionnaire covers the quality of life issues for current treatments for patients with colorectal cancer.